Navigation Links
Nventa Announces Presentation of Positive HspE7 Data from,NCI-Sponsored Clinical Trial in Cervical Dysplasia

ther than 16, suggesting cross-reactivity.

In a second presentation of data from the same cohort of 58 evaluable patients, CD4 and CD8 positive T cells were activated with pooled E6 and E7 peptides and tested for interferon gamma production and degranulation. Blinded histologic sections of the final cervical conization specimens were independently graded for inflammation using a standardized protocol (0 no inflammation and 4 the highest level of inflammation.). There was significantly more cervical inflammation in patients who did not undergo regression after HspE7 immunotherapy. Local inflammation did not correlate with type-specific HPV infection or systemic T cell responses to HPV peptides; however, this study may have been underpowered to predict these observations in this subset of women with heterogeneous T cell responses. Further studies are currently underway.

About HspE7, Lead Product Candidate:

------------------------------------

HspE7 is a novel therapeutic vaccine candidate for the treatment of diseases caused by the human papillomavirus (HPV), one of the most common sexually transmitted diseases in the world. HspE7 is derived from Nventa's proprietary CoVal(TM) fusion platform, which uses recombinant DNA technology to covalently fuse stress proteins to target antigens, thereby stimulating cellular immune system responses. Stress proteins, also known as heat shock proteins (Hsps), are naturally present in the human body and play important roles in the immune system, including transporting substances within cells and activating cells of the immune system. Nventa is pursuing clinical development of HspE7 in combination with an adjuvant.

About Nventa Corporation:

-------------------------

Nventa is developing innovative therapeutics for the treatment of viral infections and cancer, with a focus on diseases caused by the human papillomavirus (HPV). The corporation is publicly traded on the Toronto Stock Excha
'"/>




Page: 1 2 3 4 5 6

Related medicine technology :

1. Antisoma Announces Further Data From ASA404 Ovarian Cancer Trial
2. Neose Announces Presentation of Positive Preclinical Data on GlycoPEGylated Factor VIIa at the XXI Congress of the International Society on Thrombosis and Haemostasis
3. Biofrontera AG Announces Clinical Study Confirms Excellent Efficacy of BF-200 ALA In Actinic Keratosis
4. YM BioSciences Announces Secondary Efficacy and Safety Findings in Randomized Phase IIB Aerolef Trial
5. BioSante Pharmaceuticals Announces New Findings for Potential Bird Flu Vaccine
6. Portola Pharmaceuticals Announces Positive Data from a Phase II Study of its Factor Xa Inhibitor at the XXI Congress of the International Society on Thrombosis and Haemostasis
7. Manhattan Pharmaceuticals Announces Results of Phase 2a Studies for Oral Oleoyl-estrone
8. AVI BioPharma Partner Cook Medical Announces Completion of Patient Enrollment for APPRAISAL Phase II Clinical Trial for Treatment of Cardiovascular Disease
9. Protox Announces Positive Clinical Data from Prostate Cancer Study
10. Inspire Announces Webcast of Presentation at C.E. Unterberg, Towbin Emerging Growth Opportunities Conference
11. NexMed Announces Completion of Patient Enrollment in Two Pivotal Phase 3 Studies for Anti-Fungal Product

Post Your Comments:
(Date:11/6/2009)... Facet Solutions, Inc. announced today that it has... The acquisition creates an undisputed leadership ...ty and clinical experience in posterior motion pre...rom lumbar spinal stenosis," stated Facet Solution...idation further strengthens Facet Solutions, posit...
(Date:11/6/2009)...all/ -- Boston Scientific Corporation (NYSE: BSX ... in principle with the U.S. Department of Justice ...Guidant subsidiary in 2005. The alleged conduct a...ic,s 2006 acquisition of Guidant. ,, Boston Sci...by the U.S. Attorney,s Office in Minneapolis into ...
(Date:11/6/2009)... Philips Respironics applauds the efforts of the C... raise awareness about an important public health ...lease of the first-ever government study to monito... milestone in quantifying the size and scope of th...y leader and sleep therapy manufacturer, Philips R...
Breaking Medicine Technology:Facet Solutions Acquires Archus Orthopedics 2Boston Scientific Announces Agreement With DOJ On Pre-Acquisition Investigation of Guidant 2Boston Scientific Announces Agreement With DOJ On Pre-Acquisition Investigation of Guidant 3Boston Scientific Announces Agreement With DOJ On Pre-Acquisition Investigation of Guidant 4Boston Scientific Announces Agreement With DOJ On Pre-Acquisition Investigation of Guidant 5Boston Scientific Announces Agreement With DOJ On Pre-Acquisition Investigation of Guidant 6Boston Scientific Announces Agreement With DOJ On Pre-Acquisition Investigation of Guidant 7Boston Scientific Announces Agreement With DOJ On Pre-Acquisition Investigation of Guidant 8Boston Scientific Announces Agreement With DOJ On Pre-Acquisition Investigation of Guidant 9Boston Scientific Announces Agreement With DOJ On Pre-Acquisition Investigation of Guidant 10Boston Scientific Announces Agreement With DOJ On Pre-Acquisition Investigation of Guidant 11Boston Scientific Announces Agreement With DOJ On Pre-Acquisition Investigation of Guidant 12Boston Scientific Announces Agreement With DOJ On Pre-Acquisition Investigation of Guidant 13Boston Scientific Announces Agreement With DOJ On Pre-Acquisition Investigation of Guidant 14Boston Scientific Announces Agreement With DOJ On Pre-Acquisition Investigation of Guidant 15Boston Scientific Announces Agreement With DOJ On Pre-Acquisition Investigation of Guidant 16Boston Scientific Announces Agreement With DOJ On Pre-Acquisition Investigation of Guidant 17Statement by Don Spence, CEO, Philips Home Healthcare Solutions, Endorsing CDC Educational Initiatives to Raise Awareness of Sleep Deprivation 2CardioDynamics Shareholders Approve Merger Agreement with SonoSite 54251 1CardioDynamics Shareholders Approve Merger Agreement with SonoSite 54251 2CardioDynamics Shareholders Approve Merger Agreement with SonoSite 54251 3Astellas Named Elite Winner for Employee Engagement and Commitment in Chicagos 101 Best and Brightest Companies to Work For Competition 54247 1Astellas Named Elite Winner for Employee Engagement and Commitment in Chicagos 101 Best and Brightest Companies to Work For Competition 54247 2ParagonRx Sponsors Webinar on Demand By DSEC on Role of Drug Safety Officers 13507 1
... CAMBRIDGE, Mass. and COLUMBUS, Ohio, Jan. 8 Intel...ary nucleic acid assays, today announced that veri...antitative Assay are complete. , , Under the ver...ty, specificity and reproducibility and robustness...d. The data obtain agreed with internally generate...
... FREDERICK, Md., Jan. 7 ImQuest Life Sciences ann...pplication to the Food and Drug Administration to ...midinedione HIV inhibitor IQP-0410. ImQuest antici...t quarter of 2009. IQP-0410 is a novel small molec...nucleoside reverse transcriptase inhibitor (NNRTI)...
Other Medicine Technology:Verification Studies of IntelligentMDx's Proprietary Molecular Diagnostic Assay Process Have Been Completed 2Verification Studies of IntelligentMDx's Proprietary Molecular Diagnostic Assay Process Have Been Completed 3ImQuest Submits Investigational New Product Application to the Food and Drug Administration to Initiate HIV Therapeutic Clinical Trials with IQP-0410 2
(Date:11/8/2009)...drying of biopharmaceuticals to be available at th... , Toronto, ON (PRWEB) Nov... of Therapure Biopharma Inc. today announced that ...le pharmaceutical grade freeze dryer and expects t...ion) available for contract manufacturing of bioph...
(Date:11/8/2009)...f Hispanic health advocates committed to achieving...INGTON, Nov. 7 "Tonight...e heard the voice of America,s families by passing...he Senate must deliver, without delay, on the prom...ne L. Delgado, President and CEO of the National A...
(Date:11/8/2009)... of Health Care Reform Bill ,, Critical legis... for all Americans ,, CHICAGO, Nov. 7 /PRNewsw...of Representatives passed by a vote of 220-215, cr...trengthen Medicare for seniors and end discriminat... Americans out of affordable health coverage. ,...
(Date:11/7/2009)...wswire-USNewswire/ -- Speaker Nancy Pelosi spoke ...the Affordable Health Care for America Act. The H...Below are the Speaker,s remarks. ,, "Madam Spe... for our nation and for American families. For ne...al philosophy -- as far back as Teddy Roosevelt --...
(Date:11/7/2009)...-USNewswire/ -- Members of the AMA are trying a la...ion rescinding the AMA,s support of HR 3962. ,...onsible to their PATIENTS, not the leadership of t...or the Association of American Physicians and Surg... medical groups. ,, "If the AMA leadership ign...
Breaking Medicine News(10 mins):Health News:Therapure Biopharma Inc. Announces Delivery of its First Commercial-Scale Lyophilizer 2Health News:National Alliance for Hispanic Health President and CEO Applauds House Action, Calls on Senate to Pass Health Reform in 2009 2Health News:AARP Illinois Key Vote News Alert 2Health News:AARP Illinois Key Vote News Alert 3Health News:Pelosi: Health Legislation Founded on Key Principles for a Healthier America: Innovation, Competition and Prevention 2Health News:Pelosi: Health Legislation Founded on Key Principles for a Healthier America: Innovation, Competition and Prevention 3Health News:Pelosi: Health Legislation Founded on Key Principles for a Healthier America: Innovation, Competition and Prevention 4
...ncer. New research studies point towards its being...ite of vitamin D and other vitamin D analogs, may ... presented Nov. 1,// at the American Association f...th and conducted at Roswell Park Cancer Institute ...
...n skin cancer cells might be responsible for the m...o other parts of the body. // The enzyme name...al component of the healthy cell and plays a vital... community. In fact this enzyme is the culprit in ...
...ford University have found that combining anti-clo...patients may have more good effect in saving lives...ing drugs help in thinning of blood during a heart...n 45,800 patients by giving this combination drug ...
...s with only one surgeon for every one million popu...trained manpower in the country. This is comparati...d Japan where the ratio is 100,000 // and 6000 for...Sciences (AIIMS) is worried about the present tren...
...inues to entice the imagination of successive gene...ed every day. The worldwide demand for human organ...t of organ donation at a closer level.// The... the process of becoming an organ donor. Infact is...
...o counter any bird flu cases in an effective way a...ippines president Arroyo has appointed two importa...le attack and also increase the awareness to peopl...Panganiban would be responsible for organizing var...
Other Medicine News:Health News:Acute Shortage Of Neurosurgeons In India: One Surgeon For Every 1 Million! 2Health News:Survey finds that discussion with family very crucial in organ donation decision 2
Creatinine (Liquid)
Magnesium (Liquid)
Anti-Streptolysin O (ASO) Liquid
IgE
Medicine Products: